A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey - Summary - MDSpire

A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey

  • By

  • Xiao-Hui Wang

  • Zu-Zhi Wang

  • Hui-Fang Xu

  • Hong-Wei Liu

  • Dong-Ling Wang

  • Chang-Yan Feng

  • Xi Zhang

  • Wen-Jun Wang

  • Yan-Qin Yu

  • Shuang-Xia Duan

  • Ji-Hai Shi

  • Yu-Qian Zhao

  • Ma Li

  • Yun-Yong Liu

  • Juan-Xiu Huang

  • Yan-Ping Fan

  • Ji Cao

  • Xiao-Fen Gu

  • Li Li

  • Xue-Mei Lian

  • Jing-Chang Du

  • You-Lin Qiao

  • May 14, 2026

  • 0 min

Share

Objective:

To investigate key factors affecting access to multidisciplinary treatment (MDT) among patients with stage III to IV colorectal cancer (CRC) in China, particularly focusing on the inequalities in accessibility.

Key Findings:
  • Only 796 (17.3%) of the 4,589 patients participated in MDT.
  • Factors influencing MDT participation included location, hospital type, education, income, disease stage, treatment type, and quality of life.
  • Patients in North, Central, Southwest, and Northwest China had higher MDT participation rates.
  • Chemotherapy, targeted therapy, and TCM/palliative treatment were associated with increased MDT participation.
Interpretation:

Access to MDT for stage III-IV CRC patients is influenced by geographic, socioeconomic, and treatment-related factors, with MDT associated with improved quality of life, highlighting the need for targeted interventions.

Limitations:
  • The study's cross-sectional design limits causal inferences.
  • Potential selection bias due to the sampling method may affect the generalizability of the findings.
Conclusion:

Regional disparities and treatment modalities significantly affect access to MDT for stage IV CRC patients, underscoring the urgent need for policy interventions to improve accessibility.

Original Source(s)

A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey

  • by Xiao-Hui Wang, Zu-Zhi Wang, Hui-Fang Xu, Hong-Wei Liu, Dong-Ling Wang, Chang-Yan Feng, Xi Zhang, Wen-Jun Wang, Yan-Qin Yu, Shuang-Xia Duan, Ji-Hai Shi, Yu-Qian Zhao, Ma Li, Yun-Yong Liu, Juan-Xiu Huang, Yan-Ping Fan, Ji Cao, Xiao-Fen Gu, Li Li, Xue-Mei Lian, Jing-Chang Du, You-Lin Qiao

  • May 14, 2026

Related Content

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer